Bone Marrow Mesenchymal Stem Cells (BMSCs) are one of the primary cells found in the
bone marrow, and they can differentiate into osteoblasts, chondrocytes, adipocytes and even myoblasts,
and are, therefore, considered pluripotent cells. Because of their multipotential differentiation, selfrenewal
capability, immunomodulation and other potential activities, BMSCs have become an important
source of seed cells for gene therapy, tissue engineering, cell replacement therapy and regenerative
medicine. Long non-coding RNA (lncRNA) is an RNA molecule greater than 200 nucleotides in length
that is expressed in a variety of species, including animals, plants, yeast, prokaryotes, and viruses, but
lacks an apparent open reading frame, and does not have the function of translation into proteins. Many
studies have shown that lncRNAs play an important role in the osteogenic differentiation of BMSCs.
Here, we describe the role of lncRNAs in the osteogenic differentiation of BMSCs, in order to provide
a new theoretical and experimental basis for bone tissue engineering and clinical treatment.